Adam D. Cutler Navidea Biopharmaceuticals, Inc. (NAVB) insider trading activity
Adam D. Cutler is Director of NAVIDEA BIOPHARMACEUTICALS, INC.. Currently has a direct ownership of 10,000 shares of NAVB, which is worth approximately $0. The most recent transaction as insider was on Jan 13, 2021, when has been sold 2,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
10K
0%
3M change
0%
12M change
Total Value Held
$0
Adam D. Cutler Transaction History
Also insider at
ADC
Adam D. Cutler
Director
Vancouver, A1